91 related articles for article (PubMed ID: 15863657)
1. Pitfalls of automated comparative sequence analysis as a single platform for routine clinical testing for NF1.
Messiaen LM; Wimmer K
J Med Genet; 2005 May; 42(5):e25. PubMed ID: 15863657
[No Abstract] [Full Text] [Related]
2. Re: Pitfalls of automated comparative sequence analysis as a single platform for routine clinical testing for NF1 (Messiaen and Wimmer).
Whittaker JL; Mattocks C; Baralle D; Tarpey P; Ffrench-Constant C; Bobrow M
J Med Genet; 2005 Jun; 42(6):e33. PubMed ID: 15937073
[No Abstract] [Full Text] [Related]
3. Detection of a neurofibromatosis type I (NF1) homologous sequence by PCR: implications for the diagnosis and screening of genetic diseases.
Gasparini P; Grifa A; Origone P; Coviello D; Antonacci R; Rocchi M
Mol Cell Probes; 1993 Oct; 7(5):415-8. PubMed ID: 8264676
[TBL] [Abstract][Full Text] [Related]
4. Re: Pitfalls of automated comparative sequence analysis as a single platform for routine clinical testing for NF1 (Messiaen and Wimmer).
Whittaker JL; Mattocks C; Baralle D; Tarpey P; ffrench-Constant C; Bobrow M
J Med Genet; 2005 Jul; 42(7):e41. PubMed ID: 15994866
[No Abstract] [Full Text] [Related]
5. Automated comparative sequence analysis identifies mutations in 89% of NF1 patients and confirms a mutation cluster in exons 11-17 distinct from the GAP related domain.
Mattocks C; Baralle D; Tarpey P; ffrench-Constant C; Bobrow M; Whittaker J
J Med Genet; 2004 Apr; 41(4):e48. PubMed ID: 15060124
[No Abstract] [Full Text] [Related]
6. Four new DNA variants in the NF1 coding region.
Wu R; Legius E
Genet Couns; 2000; 11(2):175-8. PubMed ID: 10893669
[No Abstract] [Full Text] [Related]
7. Screening for truncated NF1 proteins.
Heim RA; Silverman LM; Farber RA; Kam-Morgan LN; Luce MC
Nat Genet; 1994 Nov; 8(3):218-9. PubMed ID: 7874161
[No Abstract] [Full Text] [Related]
8. Detection of novel NF1 mutations and rapid mutation prescreening with Pyrosequencing.
Brinckmann A; Mischung C; Bässmann I; Kühnisch J; Schuelke M; Tinschert S; Nürnberg P
Electrophoresis; 2007 Dec; 28(23):4295-301. PubMed ID: 18041031
[TBL] [Abstract][Full Text] [Related]
9. NF1 mutation rather than individual genetic variability is the main determinant of the NF1-transcriptional profile of mutations affecting splicing.
Pros E; Larriba S; López E; Ravella A; Gili ML; Kruyer H; Valls J; Serra E; Lázaro C
Hum Mutat; 2006 Nov; 27(11):1104-14. PubMed ID: 16937374
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromatosis type 1 gene mutation analysis using sequence capture and high-throughput sequencing.
Uusitalo E; Hammais A; Palonen E; Brandt A; Mäkelä VV; Kallionpää R; Jouhilahti EM; Pöyhönen M; Soini J; Peltonen J; Peltonen S
Acta Derm Venereol; 2014 Nov; 94(6):663-6. PubMed ID: 24676424
[TBL] [Abstract][Full Text] [Related]
11. COLD-PCR: a new platform for highly improved mutation detection in cancer and genetic testing.
Li J; Makrigiorgos GM
Biochem Soc Trans; 2009 Apr; 37(Pt 2):427-32. PubMed ID: 19290875
[TBL] [Abstract][Full Text] [Related]
12. Extensive in silico analysis of NF1 splicing defects uncovers determinants for splicing outcome upon 5' splice-site disruption.
Wimmer K; Roca X; Beiglböck H; Callens T; Etzler J; Rao AR; Krainer AR; Fonatsch C; Messiaen L
Hum Mutat; 2007 Jun; 28(6):599-612. PubMed ID: 17311297
[TBL] [Abstract][Full Text] [Related]
13. The potential of electrophoretic mobility shift assays for clinical mutation detection.
Hestekin CN; Barron AE
Electrophoresis; 2006 Oct; 27(19):3805-15. PubMed ID: 17031787
[TBL] [Abstract][Full Text] [Related]
14. Tumor LOH analysis provides reliable linkage information for prenatal genetic testing of sporadic NF1 patients.
Serra E; Pros E; García C; López E; Gili ML; Gómez C; Ravella A; Capellá G; Blanco I; Lázaro C
Genes Chromosomes Cancer; 2007 Sep; 46(9):820-7. PubMed ID: 17563086
[TBL] [Abstract][Full Text] [Related]
15. Reproductive decisions after prenatal diagnosis in neurofibromatosis type 1: importance of genetic counseling.
Terzi YK; Oguzkan-Balci S; Anlar B; Aysun S; Guran S; Ayter S
Genet Couns; 2009; 20(2):195-202. PubMed ID: 19650418
[TBL] [Abstract][Full Text] [Related]
16. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
Sabol Z; Kipke-Sabol L
Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
[TBL] [Abstract][Full Text] [Related]
17. LightTyper platform for high-throughput clinical genotyping.
Murugesan G; Kottke-Marchant K; Ellis S; Agah R; Tubbs R
Expert Rev Mol Diagn; 2005 May; 5(3):457-71. PubMed ID: 15934821
[TBL] [Abstract][Full Text] [Related]
18. Clinical, pathologic, and genetic features of massive soft tissue neurofibromas in a Sicilian patient.
Bongiorno MR; Cefalù AB; Aricò M; Averna M
Dermatol Ther; 2008; 21 Suppl 3():S21-5. PubMed ID: 19076627
[TBL] [Abstract][Full Text] [Related]
19. Mutation detection, interpretation, and applications in the clinical laboratory setting.
Strom CM
Mutat Res; 2005 Jun; 573(1-2):160-7. PubMed ID: 15829245
[TBL] [Abstract][Full Text] [Related]
20. Mutation screening in the human epsilon-globin gene using single-strand conformation polymorphism analysis.
Papachatzopoulou A; Menounos PG; Kolonelou C; Patrinos GP
Am J Hematol; 2006 Feb; 81(2):136-8. PubMed ID: 16432873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
